Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
10.86
+0.31 (2.99%)
Sep 14, 2026, 2:24 PM EDT - Market open
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $830.99 million as of September 14, 2026. Its market cap has increased by 216.03% in one year.
Market Cap
830.99M
Enterprise Value
678.94M
1-Year Change
216.03%
Ranking
Category
Stock Price
$10.86
ChartMarket Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $830.99M, an increase of 273.67%. That is a compound annual growth rate of 29.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 830.99M | 167.91% |
| Dec 31, 2025 | 310.18M | -15.87% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 868.49M |
| Geron | 867.34M |
| Avalo Therapeutics | 864.52M |
| Crescent Biopharma | 830.77M |
| Climb Bio | 818.47M |
| Silence Therapeutics | 783.93M |
| Aclaris Therapeutics | 783.10M |
| Nuvectis Pharma | 781.63M |